CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/Lymphoma

NCT05613348 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The company failed to provide corresponding CART services.

Conditions

B-cell Acute Lymphoblastic Leukemia
B-Cell Lymphoma, Unspecified

Interventions

BIOLOGICAL: CD19 CAR T-Cell(CAT19T2)

Sponsor

Zhujiang Hospital

Collaborators

[object Object]